3109 nab-Paclitaxel (nab-P) plus carboplatin (C) as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC): Clinical outcomes by treatment cycle. (September 2015) - Gridelli, C.; Li, L.; O'Brien, M.; Ong, T.J.; Pirker, R.; Socinski, M.A.; Thomas, M.